Correlation Between Lantern Pharma and AN2 Therapeutics
Can any of the company-specific risk be diversified away by investing in both Lantern Pharma and AN2 Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Lantern Pharma and AN2 Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Lantern Pharma and AN2 Therapeutics, you can compare the effects of market volatilities on Lantern Pharma and AN2 Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Lantern Pharma with a short position of AN2 Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Lantern Pharma and AN2 Therapeutics.
Diversification Opportunities for Lantern Pharma and AN2 Therapeutics
-0.66 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Lantern and AN2 is -0.66. Overlapping area represents the amount of risk that can be diversified away by holding Lantern Pharma and AN2 Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AN2 Therapeutics and Lantern Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Lantern Pharma are associated (or correlated) with AN2 Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AN2 Therapeutics has no effect on the direction of Lantern Pharma i.e., Lantern Pharma and AN2 Therapeutics go up and down completely randomly.
Pair Corralation between Lantern Pharma and AN2 Therapeutics
Given the investment horizon of 90 days Lantern Pharma is expected to under-perform the AN2 Therapeutics. In addition to that, Lantern Pharma is 1.32 times more volatile than AN2 Therapeutics. It trades about -0.21 of its total potential returns per unit of risk. AN2 Therapeutics is currently generating about -0.03 per unit of volatility. If you would invest 117.00 in AN2 Therapeutics on December 1, 2024 and sell it today you would lose (3.00) from holding AN2 Therapeutics or give up 2.56% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Lantern Pharma vs. AN2 Therapeutics
Performance |
Timeline |
Lantern Pharma |
AN2 Therapeutics |
Lantern Pharma and AN2 Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Lantern Pharma and AN2 Therapeutics
The main advantage of trading using opposite Lantern Pharma and AN2 Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Lantern Pharma position performs unexpectedly, AN2 Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AN2 Therapeutics will offset losses from the drop in AN2 Therapeutics' long position.Lantern Pharma vs. Beam Therapeutics | Lantern Pharma vs. Editas Medicine | Lantern Pharma vs. Caribou Biosciences | Lantern Pharma vs. Verve Therapeutics |
AN2 Therapeutics vs. Aerovate Therapeutics | AN2 Therapeutics vs. Adagene | AN2 Therapeutics vs. Acrivon Therapeutics, Common | AN2 Therapeutics vs. Rezolute |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Other Complementary Tools
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |